SCHEMBL17907939

SCHEMBL17907939

CC(C)(C)OC(=O)Cn1c(C=CC(=O)O)cc2ccc(Cl)cc21

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR9 P51686 5/20 0.42
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CCR2 P41597 1/20 0.36
OXER1 Q8TDS5 2/20 0.36
KMO O15229 1/20 0.35
CACNA1B Q00975 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
FPR2 P25090 1/20 0.33
TBXA2R P21731 1/20 0.33
PTGFR P43088 1/20 0.33
PTGER3 P43115 1/20 0.33
PTGER2 P43116 1/20 0.33
PTGIR P43119 1/20 0.33
PTGDR Q13258 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17907937 1.00 CCR9 (0.42) CCR9KDM4EALDH1A1CCR2OXER1
SCHEMBL17907951 0.91 TDP1 (0.41) KDM4EALDH1A1CCR2CACNA1BHPGD
SCHEMBL17907953 0.91 TDP1 (0.41) KDM4EALDH1A1CCR2CACNA1BHPGD
SCHEMBL17907945 0.88 ALDH1A1 (0.37) KDM4EALDH1A1CCR2CACNA1BSMN1; SMN2
SCHEMBL17907944 0.88 ALDH1A1 (0.37) KDM4EALDH1A1CCR2CACNA1BSMN1; SMN2
SCHEMBL17907946 0.86 PDE5A (0.40) KDM4EALDH1A1CCR2KMOCACNA1B
SCHEMBL17907948 0.86 PDE5A (0.40) KDM4EALDH1A1CCR2KMOCACNA1B
SCHEMBL3553083 0.85 KDM4E (0.46) KDM4EALDH1A1CCR2CACNA1B
SCHEMBL3553079 0.85 KDM4E (0.46) KDM4EALDH1A1CCR2CACNA1B
SCHEMBL26913285 0.81 KDM4E (0.33) KDM4EALDH1A1CACNA1BSMN1; SMN2TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697223-B1 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2016-07-13 EP disclosed